• Plasma cell neoplasms are monoclonal tumors of plasma cells and their precursors. (wordpress.com)
  • They are the most common soft tissue mesenchymal neoplasms. (uninsubria.it)
  • 62 per cent) and two patients (3 per cent) had a final histopathological diagnosis of malignant neoplasm. (ingentaconnect.com)
  • With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. (mdpi.com)
  • A primary or metastatic malignant neoplasm involving the larynx. (fpnotebook.com)
  • A malignant neoplasm can develop in any part of the body, such as the breast, liver, colon, and prostate. (wisegeek.com)
  • Transparency Market Research Report Added 'Malignant Neoplasm Therapeutics Market' to its database. (sbwire.com)
  • Albany, NY -- ( SBWIRE ) -- 07/26/2017 -- Malignant neoplasm is believed to be one of the extended conditions of neoplasm. (sbwire.com)
  • The very beginning of malignant neoplasm is the occurrence of abnormal patterns of growth in the tissue known as dysplasia or metaplasia. (sbwire.com)
  • In addition, factors such as advanced cancer diagnostics and early initiation of the treatment are fuelling the global malignant neoplasm therapeutics market. (sbwire.com)
  • The global malignant neoplasm treatment market has become increasingly competitive in the recent years with more player joining in. (sbwire.com)
  • On the basis of region, the global malignant neoplasm therapeutics market has been segmented into six key regions namely North America, Western Europe, Eastern Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa. (sbwire.com)
  • North America is considered as one of the largest market of malignant neoplasm therapeutics owing to a strong presence of drug manufacturers in the region and availability of advanced healthcare facilities. (sbwire.com)
  • In terms of value, the U.S accounts for a healthy portion of the global malignant neoplasm therapeutics market attributed to the growing demand for cancer treatment in the country. (sbwire.com)
  • Few of the key players identified in the global malignant neoplasm therapeutics market include F. Hoffmann-La Roche AG, Novartis International AG, Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Takeda Pharmaceutical Company Ltd, Pfizer Inc. Bayer AG, Amgen, AbbVie Inc and Celgene Corporation. (sbwire.com)
  • The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older. (news-medical.net)
  • This trial follows the recent opening of trials with SL-401 in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and relapsed/refractory acute myeloid leukemia (AML) and in patients with AML in first complete response (CR) with minimal residual disease (MRD). (cnbc.com)
  • A multicenter clinical trial with SL-401 is currently open and accruing patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) and advanced acute myeloid leukemia (AML). (cnbc.com)
  • On December 21, 2018, the Food and Drug Administration approved tagraxofusp-erzs (ELZONRIS™, Stemline Therapeutics), a CD123-directed cytotoxin, for blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older. (fda.gov)
  • Neuroendocrine neoplams (NENs) are neoplasms with a broad range of morphologic patterns, grade of differentiation, and biological behavior that share common features of neuroendocrine (NE) programming. (springer.com)
  • Depending on the nature of the myeloproliferative neoplasm, diagnostic tests may include red cell mass determination (for polycythemia), bone marrow aspirate and trephine biopsy, arterial oxygen saturation and carboxyhaemoglobin level, neutrophil alkaline phosphatase level, vitamin B 12 (or B 12 binding capacity), serum urate or direct sequencing of the patient's DNA. (wikipedia.org)
  • According to cellular differentiation, number of mitosis and local invasion, choroid plexus neoplasms can be classified as choroid plexus papillomas or carcinomas (KOESTNER et al. (thefreedictionary.com)
  • Features such as high mitotic rate, marked necrosis, nuclear atypia and solid growth are considered as malignancy indicators for choroid plexus neoplasms (RIBAS et al. (thefreedictionary.com)
  • It should be pointed out, however, that TTR is not entirely specific for choroid plexus neoplasms , since TTR immunoreactivity has been documented in several other neoplasms, retinal pigment epithelium, and hepatocytes. (thefreedictionary.com)
  • January 21, 2015 -- Ultrasound-guided biopsy of bone neoplasms yields similar accuracy to CT-guided biopsy for evaluating primary and metastatic bone lesions, while saving money, offering patient convenience, and avoiding radiation dose, according to research from the Henry Ford Health System. (auntminnie.com)
  • In dogs, unlike what is seen in humans and in some other species of domestic animals, malignant bone neoplasms are much more prevalent than benign neoplasms (Brodey 1979, Misdorp 1980, Dorfman et al. (scielo.br)
  • Clinical signs associated with primary bone neoplasms depend much more on the location than on the type of the neoplasm itself (Jongeward 1985). (scielo.br)
  • Breast Neoplasms complications. (illinois.edu)
  • Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. (labome.org)
  • A broad spectrum of nonneoplastic conditions can radiologically and clinically mimic an intracranial neoplasm. (thefreelibrary.com)
  • [ 1 ] The incidence of salivary gland neoplasms as a whole is approximately 5.5 cases per 100,000 individuals in the United States, with malignant neoplasms accounting for 0.9 cases per 100,000. (medscape.com)
  • The 1957-1958 incidence of neoplasms among the survivors of the Hiroshima A-bomb, varies directly with radiation dose insofar as it may be inferred from distance from the hypocenter at exposure. (osti.gov)
  • The incidence of all malignant neoplasms among the survivors who were within 1000 meters is more than 4 times that of the non-exposed population. (osti.gov)
  • The incidence of benign neoplasms among the survivors exposed within 1500 meters is also significantly higher than that among the non-exposed. (osti.gov)